Dear Researcher/R&D Director,
Are you facing the immense challenge of discovering highly specific, high-affinity antibody or peptide binders for your target? Do you wish to significantly shorten your development timeline and advance your project to the next milestone faster? Creative Biolabs understands the hurdles of modern drug discovery and has engineered the perfect solution: Premade Library-Based Binder Discovery Service.
This premier service is designed to be your one-stop, high-efficiency platform, delivering reliable binder discovery solutions that bypass the lengthy and resource-intensive process of de novo library construction.
Premade Antibody & Peptide Libraries
With years of experience in molecular biology operations and primer design, Creative Biolabs has built various high-quality libraries of multiple species and fragment types. We can use these libraries to provide screening services to our customers or license some of these libraries as products.
Table 1. Premade Antibody Libraries
Antibody Library ID |
Species |
Display Technology |
Library Format |
Library Size |
HuScL-6 |
Human |
pIII-fusion, Phagemid Phage Display |
Naïve scFv |
2.1×1011 |
HuScL-7 |
Human |
pIII-fusion, Phagemid Phage Display |
Naïve scFv |
1.1×1010 |
HuScL-3S |
Human |
pIII-fusion, Phagemid Phage Display |
Semi-Synthetic scFv |
>1.0×1011 |
HuFabL-4 |
Human |
pIII-fusion, Phagemid Phage Display |
Naïve Fab |
1.9×1010 |
HuFabL-5 |
Human |
pIII-fusion, Phagemid Phage Display |
Naïve Fab |
1.1×1010 |
HuFabssL-1 |
Human |
pIII-fusion, Phagemid Phage Display |
Naïve & Synthetic Fab |
1.8×1010 |
HuscL-YDP-3 |
Human |
Yeast Display |
Naïve scFv |
1.9×108 |
MuScL-2 |
Mouse |
pIII-fusion, Phagemid Phage Display |
Naïve scFv |
5.3×1010 |
MuFabL-2 |
Mouse |
pIII-fusion, Phagemid Phage Display |
Naïve Fab |
1.2×1010 |
RaFabL-1 |
Rabbit |
pIII-fusion, Phagemid Phage Display |
Naïve Fab |
7.5×109 |
RaFabL-2 |
Rabbit |
pIII-fusion, Phagemid Phage Display |
Naïve Fab |
1.2×1010 |
Chicken-ScL-2 |
Chicken |
pIII-fusion, Phagemid Phage Display |
Naïve scFv |
1.1×1010 |
CaVHHL-4 |
VHH (Camel, Llama, Alpaca) |
pIII-fusion, Phagemid Phage Display |
Naïve VHH |
2.63×1010 |
CaVHHL-5 |
VHH (Camel, Llama, Alpaca) |
pIII-fusion, Phagemid Phage Display |
Naïve VHH |
3.0×1010 |
CaVHHL-6 |
VHH (Camel, Llama, Alpaca) |
pIII-fusion, Phagemid Phage Display |
Naïve VHH |
2.43×109 |
LlaVHHL-1 |
VHH (Camel, Llama, Alpaca) |
pIII-fusion, Phagemid Phage Display |
Naïve VHH |
1.9×1010 |
LlaVHHL-2 |
VHH (Camel, Llama, Alpaca) |
pIII-fusion, Phagemid Phage Display |
Naïve VHH |
1.8×1010 |
AlVHHL-1 |
VHH (Camel, Llama, Alpaca) |
pIII-fusion, Phagemid Phage Display |
Naïve VHH |
1.35×1010 |
AlVHHL-2 |
VHH (Camel, Llama, Alpaca) |
pIII-fusion, Phagemid Phage Display |
Naïve VHH |
1.5×1011 |
LlaVHHL-S1 |
VHH (Camel, Llama, Alpaca) |
pIII-fusion, Phagemid Phage Display |
Synthetic VHH |
1.5×1011 |
CaVHHL-S2 |
VHH (Camel, Llama, Alpaca) |
pIII-fusion, Phagemid Phage Display |
Synthetic VHH |
5.4×1010 |
CaVHHL-S3 |
VHH (Camel, Llama, Alpaca) |
pIII-fusion, Phagemid Phage Display |
Synthetic VHH |
2.2×1010 |
CaVHHL-S4 |
VHH (Camel, Llama, Alpaca) |
pIII-fusion, Phagemid Phage Display |
Semi-Synthetic VHH |
5.3×1010 |
LlaVHH-YPD-1 |
VHH (Camel, Llama, Alpaca) |
Yeast Display |
Naïve VHH |
2×108 |
HuVHHL-S1 |
Humanized VHH |
pIII-fusion, Phagemid Phage Display |
Synthetic VHH |
>1.0×1011 |
HuVHHL-S2 |
Humanized VHH |
pIII-fusion, Phagemid Phage Display |
Semi-Synthetic VHH |
>1.0×1010 |
Table 2. Premade Peptide Libraries
Peptide Library ID |
Type |
Phage Display |
Library Format |
Library Size |
TriCo-16 |
Linear |
pIII-fusion, True Phage Display |
16-mer peptide library |
1.1×1010 |
TriCo-20 |
Linear |
pIII-fusion, True Phage Display |
20-mer peptide library |
1.3×1010 |
TriCo-C9 |
Cyclic |
pIII-fusion, Phagemid Phage Display |
Cyclic 9-mer peptide library |
1.10×1010 |
TriCo-C9L |
Cyclic |
pIII-fusion, Phagemid Phage Display |
Cyclic 9-mer peptide library |
6.8×1010 |
Protease-10A |
Others |
pIII-fusion, Phagemid Phage Display |
HiAffi tagged 10 mer peptide library |
1.10×1010 |
Why Choose Premade Library Screening from Creative Biolabs?
Traditional binder discovery is a long and expensive journey. By leveraging our extensive collection of world-class, ready-to-screen antibody and peptide libraries, you can save invaluable time and resources, allowing you to focus on the core science of your groundbreaking research.
Our Unmatched Advantages
- Exceptional Speed and Efficiency: Eliminate months of library construction. Our pre-built, high-quality libraries are ready for immediate screening, enabling the identification of ideal candidate molecules in as little as a few weeks and dramatically accelerating your R&D pipeline.
- Unparalleled Library Quality and Diversity: Our diverse collection of libraries—including human, murine, synthetic, scFv, Fab, and VHH—is meticulously constructed and validated to ensure massive capacity and complexity.
- State-of-the-Art Platforms & Scientific Excellence: We employ industry-leading screening platforms like Phage Display and Yeast Display, combined with sophisticated strategies including solid-phase, liquid-phase, and cell-based panning.
- Broad Application & Therapeutic Focus: Whether your research involves oncology, autoimmune disorders, or infectious diseases, or you are developing next-generation therapeutics like CAR-T therapies, ADCs, or bispecific antibodies, our services provide robust support for your diverse needs.
- Comprehensive One-Stop Services: We manage the entire workflow seamlessly, from target analysis and library selection to multiple rounds of biopanning, hit characterization, and functional validation. Throughout the process, we guarantee transparent communication and timely updates.
Take the Next Step Towards Discovery Today!
We have successfully empowered thousands of global partners, helping them expedite their research and achieve their goals. Now, we invite you to explore the technical details and success stories.
Don’t let a prolonged discovery phase slow your pace of innovation. Contact our technical experts today for a complimentary project consultation and a detailed quote. We look forward to partnering with you to turn your scientific vision into a tangible reality.
Contact Us to Learn More
|
Meet Us at the Upcoming Events |
|
- August 27–29, 2025 | 5th Oligonucleotides for CNS Summit
- September 9–11, 2025 | 16th Annual World Bispecific Summit
- September 23–25, 2025 | 7th Exosome Based Therapeutic Development Summit
- October 20–22, 2025 | Antibody Engineering & Therapeutics (Asia) 2025
- November 3–6, 2025 | 16th Annual World ADC San Diego
- November 11–13, 2025 | 17th PEGS Europe Protein & Antibody Engineering Summit
- December 14–17, 2025 | Antibody Engineering & Therapeutics (US) 2025
Book a Meeting!
|